Scarica l'app Stockscreener
18.74
1.68%
0.31
Dopo l'orario di chiusura:
19.01
0.27
+1.44%
Damora Therapeutics Inc Azioni (DMRA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Operating Expenses |
13.58%
34.99
|
30.81 | 201.70 | 3.156 | 3.421 |
| Operating Income/Loss |
13.58%
-34.99
|
-30.81 | -201.70 | -3.156 | -3.421 |
| Net Interest Income/Expense |
32.21%
4.059
|
3.07 | 1.001 | 0.042 | 0.05 |
| Nonoperating Income/Loss |
32.74%
4.075
|
3.07 | 1.004 | 0.023 | -0.012 |
| Income/Loss From Continuing Operations Before Tax |
11.46%
-30.92
|
-27.74 | -200.69 | -3.133 | -3.433 |
| Income Tax Expense/Benefit |
507.14%
0.255
|
0.042 | 0.044 | - | 0.004 |
| Net Income/Loss |
12.30%
-31.20
|
-27.78 | -200.74 | -3.10 | -3.40 |
| Basic Average Shares |
78.19%
61.12
|
34.30 | - | 1.327 | 1.3226 |
| Diluted Average Shares |
78.19%
61.12
|
34.30 | - | 1.327 | 1.3226 |
| Basic Earnings Per Share |
37.10%
-0.39
|
-0.62 | - | -2.36 | -2.60 |
| Diluted Earnings Per Share |
37.10%
-0.39
|
-0.62 | - | -2.36 | -2.60 |
| Common Stock Dividends |
-
|
- | - | - | - |
1.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):